Body of Antarctic explorer found after 66 years after his disappearance
"I had long given up on finding my brother. It is just remarkable, astonishing. I can't get over it," David Bell, Dennis' brother, told BBC News. The outlet reported that David was the one to answer the door when the family received a telegraph informing them of the bad news, which he described as a "horrendous moment."
David also told the British Antarctic Survey (BAS) that he and his sister, Valerie Kelly, were "shocked and amazed" to hear their brother's remains were found decades after his fatal accident.
Samples of David and Valerie's DNA helped Professor Denise Syndercombe Court, a forensic geneticist at King's College London, confirm that the remains were their brother's. The two were "more than one million times" more likely than not to be related, according to BAS.
After school, Bell joined the Royal Air Force for National Service and trained as a radio operator before joining the Falkland Islands Dependencies Survey (FIDS) as a meteorologist in 1958.
On July 26, 1959, Bell, along with three other men and two dog sleds, set out to climb a glacier leading to an ice plateau, where they planned to conduct survey and geological work. The men separated into pairs with Bell being accompanied by surveyor Jeff Stokes, while meteorologist Ken Gibson was with geologist Colin Barton, according to the BAS. The BAS noted that Bell and Stokes went off approximately 30 minutes before Gibson and Barton.
As the dogs grew tired in the deep, soft snow, Bell tried to motivate them by running ahead to urge them on. However, according to the BAS, he did so without his skis. That's when he fell into a crevasse, an accident that led to his death and a decades-long search for his remains.
Stokes apparently called down to Bell, who answered. He then lowered a rope and told Bell to tie it to himself. Tragically, Bell tied the rope to his belt and not his body, according to the BAS, citing Anthony Nelson's book, "Of Ice and Men." While the team tried to pull him up to safety, his belt broke, and Bell went back down into the crevasse. This time, however, Bell did not answer.
The weather worsened quickly after Bell's fall, and while his colleagues risked their lives to save him, they were unable to do so. Gibson said that after about 12 hours they found the site and realized "there was no way he could have survived," according to the BAS.
"Dennis was one of the many brave FIDS personnel who contributed to the early science and exploration of Antarctica under extraordinarily harsh conditions. Even though he was lost in 1959, his memory lived on among colleagues and in the legacy of polar research. This discovery brings closure to a decades-long mystery and reminds us of the human stories embedded in the history of Antarctic science," BAS Director Professor Dame Jane Francis said in a statement.
Bell's remains were transported to the Falkland Islands aboard the BAS Royal Research Ship Sir David Attenborough. They were then handed over to His Majesty's Coroner for the British Antarctic Territory, Malcolm Simmons, who accompanied them from Stanley in the Falkland Islands to London.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
an hour ago
- Medscape
ATOMIC Backs Atezolizumab+FOLFOX in dMMR Colon Cancer
This transcript has been edited for clarity. Hello. I'm David Kerr, professor of cancer medicine at University of Oxford. I'd like to talk about the ATOMIC trial that was presented recently at ASCO by a good pal of mine, Frank Sinicrope, from the Mayo Clinic. We don't often talk about the latest ASCO results on these Medscape videos, just because we get so much information. Those of us who are ASCO/ESMO members get bombarded — I think, appropriately — from these fantastic societies. I thought this was worthwhile given the fact that it's potentially practice changing. The ATOMIC study was of standard adjuvant chemotherapy for [patients with] stage III colon cancer, who had deficient mismatch repair/microsatellite unstable or MSI high tumors — those which we know are responsive to immunotherapy in the advanced setting. They were randomized to either chemotherapy alone for 6 months, 12 cycles of FOLFOX infusion (5-FU oxaliplatin chemotherapy), or the same chemotherapy plus the PD-L1 inhibitor atezolizumab. The atezolizumab was given in combination with FOLFOX for the first 6 months and then continued as monotherapy for a further 6 months. It's an NCI-sponsored trial from a fantastic collaborative group, and they managed to randomize 712 patients over 6 years. The trial started in 2017, and the last patient was recruited early in 2023. During that period of time, practices changed somewhat. We tend, by and large, to give 3 months rather than 6 months of adjuvant chemotherapy. The trial was of its time, though, and it was well designed. Disease-free survival was a primary outcome. They demonstrated that, in the atezolizumab arm, the disease-free survival was 86.4% compared with 76.6% in the FOLFOX arm, showing a very high P value and a very decent hazard ratio, as one would expect. Frank and colleagues concluded that, given the advantages accrued by the addition of atezolizumab to FOLFOX, in terms of disease-free survival, this should be considered a new adjuvant standard of care for patients with mismatch repair-deficient colon cancer. Yes, but no. Yes, but as I said, we tend to give 3 rather than 6 months adjuvant chemotherapy. Do we need to give chemotherapy for that long? We would argue probably not. What about atezolizumab on its own? Could that be as effective as in combination with chemotherapy? One wonders. For atezolizumab, should it be 12 months or 6 months or 24 months? There's something very interesting about the duration of exposure to atezolizumab, and of course, we'd have to look at the cost effectiveness of how we do that. Well done, Frank and team, and to the ATOMIC study group. These are very provocative data and a highly significant finding in terms of disease-free survival. Let's see what happens with more follow-up on overall survival, that will be an important additional set of secondary endpoints. There are still a number of important questions to ask in terms of toxicity of the combination, duration of therapy, and possibly financial toxicity given the cost of an immune checkpoint inhibitor. This was an important study and possibly a landmark in terms of how we treat this. It's relatively rare. Remember, only about 10% of our colon cancers will be mismatch repair deficient. It was a good trial and well run. I'd be really interested in your comments. Am I being too hard? Or should we just accept this as a new gold standard? Thanks for listening, Medscapers. For the time being, over and out. Thank you.
UPI
3 days ago
- UPI
Scientists sequence avian flu genome found in Antarctica
Penguins line the shore in South Georgia, Antarctica. A team of Chilean scientists has sequenced the first complete genomes of the H5N1 avian influenza virus found in birds in Antarctica. File Photo by L.A. Kelly Whybrow/Royal Nacy/EPA Aug. 15 (UPI) -- A team of Chilean scientists has sequenced the first complete genomes of the H5N1 avian influenza virus found in birds in Antarctica. The work, led by the University of Chile and the Chilean Antarctic Institute, was published in Emerging Infectious Diseases, a journal of the U.S. Centers for Disease Control and Prevention, marking a milestone in pathogen research on the frozen continent. The study, which included sequencing the virus in birds such as Antarctic skuas and terns, provides crucial information for understanding the evolution of H5N1 and its potential spread to other species. Sequencing a virus's genome is like reading its complete genetic code. In this case, genomic analysis of avian flu found in Antarctica showed the virus is part of the variant that has affected South America. "Sequencing and genetically characterizing this virus in Antarctic birds allows us to understand its behavior in an extreme, pristine and particularly vulnerable ecosystem," said Víctor Neira, a professor at the University of Chile's Faculty of Veterinary and Animal Sciences and a member of the research team. Specifically, the phylogenetic analysis showed a high genetic similarity to viruses detected in gulls and fur seals on South Georgia Island, confirming the existence of a viral migration route from South America to Antarctica. The finding underscores the need for constant global epidemiological surveillance and highlights the virus's risk of mutation, experts said. By infecting new species in a different environment, the virus could become more dangerous and pose a threat to human and animal health worldwide. According to the research team, its greatest contribution to Antarctic science is providing essential data on biodiversity and emerging risks in the region. In late 2023, H5N1 reached Antarctica for the first time, breaking the isolation that had kept the continent free of the virus. The first cases were recorded in skuas on South Georgia Island, and during 2024 and 2025, the virus spread to the Antarctic Peninsula and the Weddell Sea, affecting birds such as penguins, cormorants and gulls, as well as marine mammals including fur seals and elephant seals. Recent scientific expeditions detected nearly 200 infected animals from 13 species in more than 20 locations, confirming the outbreak has taken hold in the region and poses a serious threat to its fragile biodiversity.
Gizmodo
5 days ago
- Gizmodo
The Bizarre Biological Trick That Makes Mollusk Teeth Tougher Than Steel
At first glance, chitons look like any other mollusk: round, bashful creatures creeping across seashore rocks. Flip one over, however, and you'll notice rows of freakishly sharp, polished teeth—indestructible, multi-purpose chompers that researchers are seeking to replicate for the next breakthrough in material science. A new study published August 7 in Science presents a detailed investigation into what makes chiton teeth so strong and durable. By analyzing chiton anatomy, the team found a remarkably precise, consistent stream of iron-binding proteins that resulted in dental structures 'superior to materials used in industrial cutting tools, grinding media, dental implants, surgical implants, and protective coatings,' paper co-author David Kisalilus explained in a statement. Even more impressive is the fact that, unlike human-made materials, chitons produce their teeth at room temperature with nanoscale precision, he added. The new paper lays out the underlying mechanisms of this process, which the researchers believe could inform future advances in the fabrication of advanced materials. 'We can learn a lot from these biological designs and processes,' said Kisalius, a materials scientist at the University of California. Kisalius collaborated with research partners in Japan to study larger types of chitons found in the northwest United States and the coasts of Hokkaido, Japan. They identified a protein, RTMP1, which is unique to chitons and enables the deposition of iron onto the mollusks' teeth. Scientists knew that this allowed chitons to scrape off stubborn bits of algae from rock, but it was unknown how and when these proteins interacted with chiton teeth. Using tools from both material science and molecular biology, the researchers built the protein's itinerary through chiton anatomy 'from the ground up,' Kisalilus explained. First, RTMP1 travels through nanoscopic tubes leading out from each tooth, then binds to compounds that control the architecture of magnetite, a type of iron oxide. At the same time, the protein releases the iron stored in ferritin, another protein found in the tissues near chiton teeth. As a result, the new teeth grow into neat rows of ultrahard structures that also grow back after a certain amount of wear. The results demonstrate a fantastic opportunity for humans to learn from nature. Further investigations into chiton teeth could inform 'spatially and temporally controlled synthesis of other materials for a broad range of applications, such as batteries, fuel cell catalysts, and semiconductors,' Kisailus said, in addition to 'new approaches toward additive manufacturing—3D printing—and synthesis methods that are far more environmentally friendly and sustainable.' Those are perhaps grand expectations for a creature as visually unassuming as the chiton. Then again, these mollusks look extra metal when flipped over (both literally and figuratively). So who knows? Maybe chiton dental steel will truly be the next big thing in materials science.
